title: Hypertrophic cardiomyopathy: a real risk factor for stroke.
abstract: Hypertrophic cardiomyopathy is a common and complex heterogeneous cardiovascular entity. Its relationship to ischaemic stroke and atrial fibrillation is under-recognized and consequently, many patients who should be on oral anticoagulation for stroke prevention go untreated.
authors.affiliation: Department of Interventional Cardiology, The John Ochsner Heart & Vascular Institute, New Orleans, LA 70121, USA. rbadawi@msn.com
authors.forename: R A
authors.initials: RA
authors.lastname: Badawi
authors.forename: S
authors.initials: S
authors.lastname: Seetharaman
authors.forename: J
authors.initials: J
authors.lastname: Birns
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D006801:Humans; D055118:Medication Adherence; D012307:Risk Factors; D020521:Stroke / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants